HADH

UniProt ID: Q16836
Organism: Homo sapiens
Review Status: COMPLETE
📝 Provide Detailed Feedback

Gene Description

HADH (Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial; also known as SCHAD, HAD1, M/SCHAD) is a soluble mitochondrial matrix enzyme that catalyzes the third step of the fatty-acid beta-oxidation spiral: the NAD+-dependent oxidation of L-(3S)-3-hydroxyacyl-CoA to 3-ketoacyl-CoA (EC 1.1.1.35). It acts as a homodimer and preferentially oxidizes short- and medium-chain 3-hydroxyacyl-CoA substrates (roughly C4-C10), functionally distinct from the long-chain, membrane-associated mitochondrial trifunctional protein alpha subunit (HADHA). Catalysis uses His158 as a general base assisted by Glu170. Beyond its catalytic role, HADH has a well-documented regulatory (moonlighting) function in pancreatic beta-cells: it binds and inhibits the activation of glutamate dehydrogenase 1 (GLUD1), thereby restraining amino-acid-stimulated insulin secretion. Loss of HADH function causes hyperinsulinaemic hypoglycaemia and a fatty-acid-oxidation disorder, establishing the first known link between beta-oxidation and dysregulated insulin secretion. HADH is expressed in liver, kidney, pancreatic islets, heart, skeletal muscle, and adipose tissue, and in rodents contributes to body-weight regulation and adaptive thermogenesis.

Existing Annotations Review

GO Term Evidence Action Reason
GO:0003857 (3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity
IBA
GO_REF:0000033
ACCEPT
Summary: Phylogenetically inferred core molecular function. This is the defining catalytic activity of HADH/SCHAD, directly demonstrated for the human enzyme by purified-protein biochemistry and crystallography and by patient-mutant expression studies. The IBA call is at the correct level of specificity and is strongly corroborated by experimental annotations on the same term.
Reason: Bona fide enzymatic function supported across the 3-hydroxyacyl-CoA dehydrogenase family and by direct human experimental data (PMID:10231530, PMID:11489939, PMID:16725361).
Supporting Evidence:
PMID:10231530
catalyzes the oxidation of the hydroxyl group of L-3-hydroxyacyl-CoA to a keto group, concomitant with the reduction of NAD+ to NADH
GO:0005739 mitochondrion
IBA
GO_REF:0000033
KEEP AS NON CORE
Summary: HADH is a mitochondrial matrix enzyme, so a mitochondrial location is correct. However, 'mitochondrion' is the generic parent of the more precise and experimentally supported 'mitochondrial matrix' (GO:0005759). Correct but non-core; the matrix term should carry the core localization.
Reason: Correct compartment but less specific than the supported mitochondrial matrix annotation.
GO:0006635 fatty acid beta-oxidation
IBA
GO_REF:0000033
ACCEPT
Summary: Core biological process. HADH catalyzes the third step of the mitochondrial beta-oxidation cycle; this is its principal pathway role, supported by enzymology, the UniProt-curated pathway assignment, and patient deficiency phenotypes.
Reason: Directly supported by experimental data and UniProt pathway curation (lipid metabolism; fatty acid beta-oxidation).
Supporting Evidence:
PMID:11489939
This is the first defect in fatty acid beta-oxidation that has been associated with hyperinsulinism
GO:0003857 (3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity
IEA
GO_REF:0000120
ACCEPT
Summary: Electronic (multi-method) inference of the core catalytic activity. Redundant with the experimental and IBA annotations on the same term and correct.
Reason: Same correct molecular function as the experimentally supported annotation.
GO:0005759 mitochondrial matrix
IEA
GO_REF:0000044
ACCEPT
Summary: Correct and specific subcellular localization derived from the UniProt subcellular-location vocabulary. HADH is a soluble matrix homodimer; this is the appropriate core location term and is independently supported by TAS (Reactome) and high-confidence mitochondrial proteomics.
Reason: Matches the curated UniProt 'Mitochondrion matrix' location and is the most precise localization for HADH.
GO:0006631 fatty acid metabolic process
IEA
GO_REF:0000002
KEEP AS NON CORE
Summary: Correct but generic. 'Fatty acid metabolic process' is a high-level parent of the specific and experimentally supported 'fatty acid beta-oxidation' (GO:0006635). Keep as non-core in favor of the more informative beta-oxidation term.
Reason: Subsumed by the more specific beta-oxidation annotation.
GO:0016491 oxidoreductase activity
IEA
GO_REF:0000002
KEEP AS NON CORE
Summary: Correct but maximally generic molecular-function class. HADH is an NAD+-dependent oxidoreductase, but this term is a distant parent of the specific GO:0003857 activity.
Reason: Generic parent of the specific dehydrogenase activity; uninformative as a standalone core function.
GO:0016509 long-chain (3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity
IEA
GO_REF:0000116
MARK AS OVER ANNOTATED
Summary: This Rhea-mapped annotation asserts long-chain (C16) 3-hydroxyacyl-CoA dehydrogenase activity. HADH is the SHORT/medium-chain enzyme (preferring C4-C10); the long-chain matrix activity is the dedicated function of HADHA (MTP alpha subunit). UniProt lists a long-chain Rhea reaction for HADH only 'By similarity' to pig liver SCHAD (P00348), not as a preferred human activity. Annotating HADH with the long-chain-specific term misrepresents substrate preference and overlaps the distinct HADHA function.
Reason: HADH preferentially oxidizes short/medium-chain (C4-C10) 3-hydroxyacyl-CoAs; long-chain activity is minor/by-similarity and is the defining role of the paralog HADHA. The substrate-general GO:0003857 already captures the correct activity.
GO:0016616 oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
IEA
GO_REF:0000002
KEEP AS NON CORE
Summary: Correct but generic intermediate parent of GO:0003857. Accurately describes the chemistry (oxidation of a CH-OH group with NAD+ as acceptor) but is less informative than the specific activity term.
Reason: Generic parent of the specific 3-hydroxyacyl-CoA dehydrogenase activity.
GO:0070403 NAD+ binding
IEA
GO_REF:0000002
KEEP AS NON CORE
Summary: NAD+ is the cofactor for the dehydrogenase reaction and binding is documented crystallographically. Correct molecular detail of the catalytic mechanism; complementary to (and subordinate to) the core dehydrogenase activity rather than a standalone core function.
Reason: Cofactor-binding activity supporting the core catalytic function; also captured by the IDA annotation from PMID:10840044.
GO:0005739 mitochondrion
IEA
GO_REF:0000107
KEEP AS NON CORE
Summary: Correct mitochondrial localization by orthology transfer, but generic relative to the specific 'mitochondrial matrix' term.
Reason: Less specific than the supported mitochondrial matrix annotation.
GO:0006635 fatty acid beta-oxidation
IEA
GO_REF:0000120
ACCEPT
Summary: Electronic inference of the core beta-oxidation process, redundant with and consistent with the experimental (IDA) and IBA annotations on this term.
Reason: Correct core biological process supported by experimental evidence.
GO:0009410 response to xenobiotic stimulus
IEA
GO_REF:0000107
KEEP AS NON CORE
Summary: Electronically transferred from a rodent ortholog (rat Q9WVK7). A generic physiological 'response' term with no mechanistic link to HADH's molecular function; weakly informative and not part of the gene's core biology.
Reason: Orthology-transferred generic response term; not contradicted but low information and not a core function.
GO:0009725 response to hormone
IEA
GO_REF:0000107
KEEP AS NON CORE
Summary: Generic 'response to hormone' transferred electronically from a rodent ortholog. Broad and mechanistically uninformative for HADH.
Reason: Orthology-transferred generic term; non-core.
GO:0014823 response to activity
IEA
GO_REF:0000107
KEEP AS NON CORE
Summary: Generic physiological response term transferred from a rodent ortholog; not informative about HADH molecular function.
Reason: Orthology-transferred generic term; non-core.
GO:0032868 response to insulin
IEA
GO_REF:0000107
KEEP AS NON CORE
Summary: Generic 'response to insulin' transferred from a rodent ortholog. While HADH biology is linked to insulin (through its regulatory effect ON secretion), 'response to insulin' is a distinct, broad term and is mechanistically uninformative here.
Reason: Orthology-transferred generic response term; the relevant insulin biology is captured by the regulation-of-insulin-secretion annotations.
GO:0046676 negative regulation of insulin secretion
IEA
GO_REF:0000107
KEEP AS NON CORE
Summary: Captures HADH's regulatory (moonlighting) role in pancreatic beta-cells: by binding and inhibiting GLUD1, HADH restrains amino-acid-stimulated insulin secretion, so its loss leads to inappropriate insulin oversecretion (hyperinsulinism). This is the more mechanistically precise insulin-secretion term and is well supported by human disease and mouse knockout data. Genuine secondary function.
Reason: Well-supported regulatory function (GDH inhibition / restraint of insulin secretion), but secondary to the core beta-oxidation enzymatic role.
Supporting Evidence:
PMID:21990309
insulin secretion in response to glucose and glucose plus palmitate was elevated in isolated islets of knockout mice
GO:0050796 regulation of insulin secretion
IEA
GO_REF:0000107
KEEP AS NON CORE
Summary: Parent term of 'negative regulation of insulin secretion'. Correct and supported, but less precise than the negative-regulation child that matches the GDH-inhibition mechanism.
Reason: Correct regulatory role but subsumed by the more specific negative-regulation term.
GO:0120162 positive regulation of cold-induced thermogenesis
IEA
GO_REF:0000107
KEEP AS NON CORE
Summary: Based on the mouse Hadh knockout phenotype (impaired cold tolerance / adaptive thermogenesis). This is a downstream physiological consequence of impaired fatty-acid oxidation rather than a distinct molecular function of HADH; appropriate to retain as a non-core, organism-level process.
Reason: Mouse-derived physiological phenotype downstream of FAO; non-core.
Supporting Evidence:
PMID:21990309
SCHAD plays an important role in adaptive thermogenesis
GO:0005739 mitochondrion
IDA
GO_REF:0000052
KEEP AS NON CORE
Summary: Direct (immunofluorescence/HPA) evidence for mitochondrial localization. Correct; generic relative to the matrix sub-compartment but a valid experimental localization.
Reason: Experimentally supported mitochondrial localization, less specific than mitochondrial matrix.
GO:0003857 (3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity
EXP
PMID:10231530
Biochemical characterization and crystal structure determina...
ACCEPT
Summary: Direct experimental demonstration of the core catalytic activity via purified recombinant human heart SCHAD, kinetics, and crystal structures of the enzyme with NAD+ and substrate. This is the strongest evidence for HADH's defining molecular function.
Reason: Gold-standard experimental evidence for the core dehydrogenase activity.
Supporting Evidence:
PMID:10231530
catalyzes the oxidation of the hydroxyl group of L-3-hydroxyacyl-CoA to a keto group, concomitant with the reduction of NAD+ to NADH
GO:0003857 (3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity
EXP
PMID:16725361
Reye-like syndrome resulting from novel missense mutations i...
ACCEPT
Summary: Experimental support from kinetic analysis of patient-derived missense mutants (D45G with altered NADH Km; Y214H with no detectable activity), directly assaying the human SCHAD 3-hydroxyacyl-CoA dehydrogenase activity.
Reason: Independent experimental confirmation of the core dehydrogenase activity through mutant enzymology.
GO:0005739 mitochondrion
HTP
PMID:34800366
Quantitative high-confidence human mitochondrial proteome an...
KEEP AS NON CORE
Summary: High-throughput high-confidence mitochondrial proteomics confirming HADH as a mitochondrial protein. Correct; generic relative to the matrix term but a valid orthogonal localization evidence source.
Reason: Supports mitochondrial localization; less specific than mitochondrial matrix.
GO:0050796 regulation of insulin secretion
ISS
GO_REF:0000024
KEEP AS NON CORE
Summary: Sequence-similarity transfer (from mouse Q61425) of HADH's regulatory role in insulin secretion. Reflects the GDH-inhibition moonlighting mechanism. Correct and supported, but less precise than the negative-regulation child term and secondary to the core enzymatic function.
Reason: Genuine but secondary regulatory function; the negative-regulation term is more precise.
Supporting Evidence:
PMID:21990309
Blood glucose concentrations in the fasted and postprandial state were significantly lower in hadh(-/-) mice, whereas insulin levels were elevated
GO:0070403 NAD+ binding
IDA
PMID:10840044
Sequestration of the active site by interdomain shifting. Cr...
KEEP AS NON CORE
Summary: Direct crystallographic/spectroscopic evidence for NAD+/NADH binding within distinct enzyme conformations. A molecular detail underpinning the catalytic mechanism; complementary to the core dehydrogenase activity.
Reason: Cofactor-binding activity supporting, but subordinate to, the core catalytic function.
Supporting Evidence:
PMID:10840044
significant shifting of the NAD(+)-binding domain relative to the C-terminal domain occurs in the ternary and substrate-bound complexes
GO:0042802 identical protein binding
IDA
PMID:10231530
Biochemical characterization and crystal structure determina...
KEEP AS NON CORE
Summary: Reflects the fact that HADH is an obligate homodimer, established by crystallography and biochemistry. This is a quaternary-structure descriptor ('identical protein binding') rather than the bare uninformative 'protein binding', and it is experimentally grounded. It is not, however, a core catalytic/regulatory function in its own right.
Reason: Experimentally supported self-association (homodimerization); structural property rather than a core function.
Supporting Evidence:
PMID:10231530
The homodimeric enzyme has been overexpressed in Escherichia coli, purified to homogeneity
GO:0003857 (3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity
IDA
PMID:11489939
Hyperinsulinism in short-chain L-3-hydroxyacyl-CoA dehydroge...
ACCEPT
Summary: Direct assay of the core activity in patient material and recombinant enzyme: SCHAD activity was markedly reduced in patient fibroblast mitochondria and the P258L variant had no catalytic activity, confirming HADH as the enzyme catalyzing this reaction.
Reason: Experimental loss-of-function evidence directly tying HADH to the 3-hydroxyacyl-CoA dehydrogenase activity.
Supporting Evidence:
PMID:11489939
Expression studies showed that the P258L enzyme had no catalytic activity
GO:0006635 fatty acid beta-oxidation
IDA
PMID:11489939
Hyperinsulinism in short-chain L-3-hydroxyacyl-CoA dehydroge...
ACCEPT
Summary: Direct evidence linking HADH to beta-oxidation: deficiency produces a fatty-acid-oxidation disorder with characteristic 3-hydroxy-acylcarnitine accumulation, the first FAO defect associated with hyperinsulinism.
Reason: Experimentally supported core biological process (beta-oxidation).
Supporting Evidence:
PMID:11489939
This is the first defect in fatty acid beta-oxidation that has been associated with hyperinsulinism
GO:0120162 positive regulation of cold-induced thermogenesis
ISS
PMID:21990309
Role of medium- and short-chain L-3-hydroxyacyl-CoA dehydrog...
KEEP AS NON CORE
Summary: Sequence-similarity annotation citing the mouse Hadh knockout thermogenesis phenotype. Downstream physiological consequence of impaired fatty-acid oxidation rather than a distinct molecular function; retain as non-core.
Reason: Mouse-derived organismal phenotype downstream of FAO; non-core.
Supporting Evidence:
PMID:21990309
SCHAD plays an important role in adaptive thermogenesis
GO:0005759 mitochondrial matrix
TAS
Reactome:R-HSA-77254
ACCEPT
Summary: Reactome traceable assertion placing HADH in the mitochondrial matrix as part of a beta-oxidation reaction (3-hydroxydodecanoyl-CoA oxidation). Correct, specific localization consistent with UniProt.
Reason: Correct, specific mitochondrial matrix localization from curated pathway data.
GO:0005759 mitochondrial matrix
TAS
Reactome:R-HSA-77312
ACCEPT
Summary: Reactome matrix localization within the short-chain (3-hydroxybutanoyl-CoA) beta-oxidation reaction. Correct and consistent with the curated location.
Reason: Correct mitochondrial matrix localization from curated pathway data.
GO:0005759 mitochondrial matrix
TAS
Reactome:R-HSA-77323
ACCEPT
Summary: Reactome matrix localization within the hexanoyl-CoA beta-oxidation reaction. Correct, consistent with curated location.
Reason: Correct mitochondrial matrix localization from curated pathway data.
GO:0005759 mitochondrial matrix
TAS
Reactome:R-HSA-77331
ACCEPT
Summary: Reactome matrix localization within the octanoyl-CoA beta-oxidation reaction. Correct, consistent with curated location.
Reason: Correct mitochondrial matrix localization from curated pathway data.
GO:0005759 mitochondrial matrix
TAS
Reactome:R-HSA-77342
ACCEPT
Summary: Reactome matrix localization within the decanoyl-CoA beta-oxidation reaction. Correct, consistent with curated location.
Reason: Correct mitochondrial matrix localization from curated pathway data.
GO:0005759 mitochondrial matrix
TAS
Reactome:R-HSA-9838035
ACCEPT
Summary: This Reactome reaction is 'CLPXP binds mitochondrial matrix proteins'; HADH is annotated here as a matrix substrate of the quality-control protease, which correctly localizes it to the matrix. The location assertion is valid; it does not imply any protease/degradation function for HADH itself.
Reason: Valid matrix localization arising from HADH being a CLPXP substrate (localization-only, not a HADH function).
GO:0005759 mitochondrial matrix
TAS
Reactome:R-HSA-9838081
ACCEPT
Summary: Reactome 'LONP1 degrades mitochondrial matrix proteins'; HADH appears as a matrix substrate, correctly localizing it to the matrix. Location-only evidence, not a degradation function of HADH.
Reason: Valid matrix localization from HADH being a LONP1 substrate (localization-only).
GO:0005759 mitochondrial matrix
TAS
Reactome:R-HSA-9838093
ACCEPT
Summary: Reactome 'LONP1 binds mitochondrial matrix proteins'; HADH appears as a matrix substrate. Correct localization; location-only, not a HADH function.
Reason: Valid matrix localization from HADH being a LONP1 substrate (localization-only).
GO:0005759 mitochondrial matrix
TAS
Reactome:R-HSA-9838289
ACCEPT
Summary: Reactome 'CLPXP degrades mitochondrial matrix proteins'; HADH appears as a matrix substrate. Correct localization; location-only, not a HADH function.
Reason: Valid matrix localization from HADH being a CLPXP substrate (localization-only).
GO:0005737 cytoplasm
IDA
GO_REF:0000054
MARK AS OVER ANNOTATED
Summary: A LIFEdb annotation based on localization of an expressed fluorescent fusion protein in living cells. HADH is a mitochondrial matrix enzyme with a cleavable N-terminal mitochondrial targeting peptide; a cytoplasmic call most likely reflects mislocalization of the overexpressed fusion construct (e.g., incomplete import or a tag obscuring the transit peptide) rather than the native location. Contradicted by curated UniProt localization, Reactome, HPA, and high-confidence mitochondrial proteomics.
Reason: Likely overexpression/fusion-protein artifact; HADH is matrix-localized, not cytoplasmic.
GO:0003857 (3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity
TAS
PMID:8687463
Human short-chain L-3-hydroxyacyl-CoA dehydrogenase: cloning...
ACCEPT
Summary: Traceable assertion from the original human SCHAD cDNA cloning/characterization paper, which identified the protein as short-chain L-3-hydroxyacyl-CoA dehydrogenase. Correct core molecular function.
Reason: Consistent with the experimentally established core dehydrogenase activity.
Supporting Evidence:
PMID:8687463
The cDNA encompassing the complete coding sequence of human liver short-chain L-3-hydroxyacyl-CoA dehydrogenase (SCHAD) was isolated and characterized
GO:0005739 mitochondrion
TAS
PMID:8687463
Human short-chain L-3-hydroxyacyl-CoA dehydrogenase: cloning...
KEEP AS NON CORE
Summary: Traceable assertion of mitochondrial localization from the cloning paper, which identified a 12-residue mitochondrial import signal peptide. Correct; generic relative to the matrix term.
Reason: Correct mitochondrial localization, less specific than mitochondrial matrix.
Supporting Evidence:
PMID:8687463
containing a mitochondrial import signal peptide of 12 amino acids

Core Functions

Core enzymatic function: HADH catalyzes the third step of the mitochondrial fatty-acid beta-oxidation spiral, the NAD+-dependent oxidation of L-(3S)-3-hydroxyacyl-CoA to 3-ketoacyl-CoA, acting as a soluble homodimer in the mitochondrial matrix and preferring short/medium-chain (C4-C10) substrates.

Supporting Evidence:
  • PMID:10231530
    catalyzes the oxidation of the hydroxyl group of L-3-hydroxyacyl-CoA to a keto group, concomitant with the reduction of NAD+ to NADH
  • PMID:11489939
    Expression studies showed that the P258L enzyme had no catalytic activity

Secondary (moonlighting) regulatory function: in pancreatic beta-cells HADH binds and inhibits the activation of glutamate dehydrogenase 1 (GLUD1), thereby restraining amino-acid-stimulated insulin secretion. Loss of HADH de-represses GLUD1 and causes inappropriate insulin oversecretion (hyperinsulinaemic hypoglycaemia), a phenotype reproduced in Hadh knockout mice and partly independent of beta-oxidation flux. The underlying molecular activity is enzyme (GLUD1) inhibitor activity; the physiological output is negative regulation of insulin secretion.

Supporting Evidence:
  • PMID:20670938
    showed protein-protein interactions between SCHAD and GDH
  • PMID:20670938
    reflecting the loss of an inhibitory protein-protein interaction of SCHAD upon GDH
  • PMID:21990309
    insulin secretion in response to glucose and glucose plus palmitate was elevated in isolated islets of knockout mice

References

Gene Ontology annotation through association of InterPro records with GO terms
Manual transfer of experimentally-verified manual GO annotation data to orthologs by curator judgment of sequence similarity
Annotation inferences using phylogenetic trees
Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location vocabulary mapping, accompanied by conservative changes to GO terms applied by UniProt
Gene Ontology annotation based on curation of immunofluorescence data
Gene Ontology annotation based on curation of intracellular localizations of expressed fusion proteins in living cells
Automatic transfer of experimentally verified manual GO annotation data to orthologs using Ensembl Compara
Automatic Gene Ontology annotation based on Rhea mapping
Combined Automated Annotation using Multiple IEA Methods
Biochemical characterization and crystal structure determination of human heart short chain L-3-hydroxyacyl-CoA dehydrogenase provide insights into catalytic mechanism.
  • Human heart SCHAD catalyzes NAD+-dependent oxidation of L-3-hydroxyacyl-CoA to a 3-keto product as part of beta-oxidation; the enzyme is a homodimer and was characterized biochemically and crystallographically with NAD+/substrate.
    "catalyzes the oxidation of the hydroxyl group of L-3-hydroxyacyl-CoA to a keto group, concomitant with the reduction of NAD+ to NADH"
  • Catalytic mechanism: His158 acts as a general base abstracting the 3-OH proton, assisted by Glu170.
    "His 158 serves as a general base, abstracting a proton from the 3-OH group of the substrate"
Sequestration of the active site by interdomain shifting. Crystallographic and spectroscopic evidence for distinct conformations of L-3-hydroxyacyl-CoA dehydrogenase.
  • Crystal structures of apo-, cofactor-, and substrate-bound forms reveal NAD+-binding domain shifting relative to the C-terminal domain; supports NAD+ binding and catalytic mechanism.
    "significant shifting of the NAD(+)-binding domain relative to the C-terminal domain occurs in the ternary and substrate-bound complexes"
Hyperinsulinism in short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency reveals the importance of beta-oxidation in insulin secretion.
  • First report linking a fatty-acid-oxidation defect (SCHAD/HADH deficiency, P258L) to hyperinsulinism, establishing HADH's role in insulin-secretion regulation.
    "This is the first defect in fatty acid beta-oxidation that has been associated with hyperinsulinism"
  • The disease-causing P258L variant abolishes catalytic activity, directly tying HADH to the 3-hydroxyacyl-CoA dehydrogenase reaction.
    "Expression studies showed that the P258L enzyme had no catalytic activity"
Reye-like syndrome resulting from novel missense mutations in mitochondrial medium- and short-chain l-3-hydroxy-acyl-CoA dehydrogenase.
  • Kinetic analysis of patient-derived M/SCHAD mutants (D45G altered NADH Km; Y214H no activity) confirms the human enzyme's 3-hydroxyacyl-CoA dehydrogenase activity and broadens the phenotype; supports a role in insulin regulation.
    "This association suggests that there is a role for M/SCHAD in regulating the pancreatic secretion of insulin"
Mechanism of hyperinsulinism in short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency involves activation of glutamate dehydrogenase.
  • Definitive mechanistic paper: pull-down experiments demonstrate a direct protein-protein interaction between SCHAD (HADH) and glutamate dehydrogenase (GDH), and show that SCHAD deficiency activates GDH by removing this inhibitory interaction, dysregulating amino-acid-stimulated insulin secretion. Establishes the GLUD1-inhibitor moonlighting function on firmer footing than the earlier speculative reports.
    "reflecting the loss of an inhibitory protein-protein interaction of SCHAD upon GDH"
Role of medium- and short-chain L-3-hydroxyacyl-CoA dehydrogenase in the regulation of body weight and thermogenesis.
  • Hadh-knockout mice show low glucose and elevated insulin, and isolated islets hypersecrete insulin in response to glucose and palmitate, supporting HADH's negative regulation of insulin secretion.
    "insulin secretion in response to glucose and glucose plus palmitate was elevated in isolated islets of knockout mice"
  • Hadh knockout impairs adaptive thermogenesis and body-weight regulation under high-fat/cold conditions.
    "SCHAD plays an important role in adaptive thermogenesis"
  • SCHAD/HADH is highly expressed in pancreatic islets of Langerhans, consistent with a direct role in beta-cell function.
    "in the islets of Langerhans within the pancreas"
Quantitative high-confidence human mitochondrial proteome and its dynamics in cellular context.
  • HADH is identified in a high-confidence quantitative human mitochondrial proteome, corroborating its mitochondrial localization.
    "Quantitative high-confidence human mitochondrial proteome and its dynamics"
Human short-chain L-3-hydroxyacyl-CoA dehydrogenase: cloning and characterization of the coding sequence.
  • Original cloning of human SCHAD cDNA; encodes a 314-aa protein with a 12-residue mitochondrial import peptide; expressed in liver, kidney, pancreas, heart and skeletal muscle.
    "Northern blot analysis reveals SCHAD mRNA to be expressed in liver, kidney, pancreas, heart and skeletal muscle"
Reactome:R-HSA-77254
(S)-3-Hydroxydodecanoyl-CoA+NAD => 3-Oxododecanoyl-CoA+NADH+H
Reactome:R-HSA-77312
(S)-Hydroxybutanoyl-CoA+NAD => Acetoacetyl-CoA+NADH+H
Reactome:R-HSA-77323
(S)-Hydroxyhexanoyl-CoA+NAD => 3-Oxohexanoyl-CoA+NADH+H
Reactome:R-HSA-77331
(S)-Hydroxyoctanoyl-CoA+NAD => 3-Oxooctanoyl-CoA+NADH+H
Reactome:R-HSA-77342
(S)-Hydroxydecanoyl-CoA+NAD => 3-Oxodecanoyl-CoA+NADH+H
Reactome:R-HSA-9838035
CLPXP binds mitochondrial matrix proteins
Reactome:R-HSA-9838081
LONP1 degrades mitochondrial matrix proteins
Reactome:R-HSA-9838093
LONP1 binds mitochondrial matrix proteins
Reactome:R-HSA-9838289
CLPXP degrades mitochondrial matrix proteins

Suggested Questions for Experts

Q: To what extent is HADH's regulation of insulin secretion mediated by direct GLUD1 inhibition versus by perturbation of short-chain acyl-CoA/3-hydroxyacyl-CoA pools from impaired beta-oxidation, and are these mechanisms separable in human beta-cells?

Q: Is the HADH-GLUD1 inhibitory interaction conserved and direct in human tissue (as opposed to the By-similarity/mouse-based evidence currently underpinning it), and what is its stoichiometry and regulation?

Suggested Experiments

Experiment: Reconstitute purified human HADH with human GLUD1 in vitro and measure GLUD1 activity +/- HADH (and +/- HADH catalytic-dead mutants) to determine whether enzyme-inhibitor activity is independent of HADH's own catalysis.

Experiment: Generate beta-cell models expressing a catalytically dead but folding-competent HADH variant versus full knockout to dissociate the dehydrogenase activity from the GLUD1-inhibition / insulin-secretion-restraint function.

Experiment: Perform substrate-profiling (chain-length kinetics) on purified human HADH across C4-C16 3-hydroxyacyl-CoAs to quantitatively confirm short/medium-chain preference and the negligible long-chain activity relative to HADHA.

📚 Additional Documentation

Notes

(HADH-notes.md)

HADH (Q16836) review notes

Gene: HADH (HGNC:4799); aka SCHAD, HAD1, HADHSC, M/SCHAD.
Protein: Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial (HCDH_HUMAN). 314 aa precursor;
12-aa mitochondrial transit peptide; mature 13-314. EC 1.1.1.35.

Core enzymatic function (SCHAD, EC 1.1.1.35)

HADH catalyzes the third step of the mitochondrial fatty-acid beta-oxidation spiral: the
NAD+-dependent oxidation of L-(3S)-3-hydroxyacyl-CoA to 3-ketoacyl-CoA.

  • UniProt FUNCTION: "Mitochondrial fatty acid beta-oxidation enzyme that catalyzes the third
    step of the beta-oxidation cycle for medium and short-chain 3-hydroxy fatty acyl-CoAs (C4 to
    C10)" [Q16836 UniProt, ECO:0000269|PubMed:10231530, 11489939, 16725361].
  • Reaction (Rhea:22432): "a (3S)-3-hydroxyacyl-CoA + NAD(+) = a 3-oxoacyl-CoA + NADH + H(+)";
    EC=1.1.1.35 [Q16836 UniProt CATALYTIC ACTIVITY].
  • Substrate preference is short/medium chain. PMID:10231530
  • Homodimer; crystal structures solved with NAD+/substrate. PMID:10231530
  • Catalytic mechanism: His158 general base, Glu170 electrostatic assist PMID:10231530.
  • Conformational interdomain shifting on cofactor/substrate binding PMID:10840044.

Distinct from HADHA (the long-chain, membrane-bound MTP alpha subunit). HADH is a soluble
matrix homodimer.

Subcellular location

Mitochondrion matrix. [Q16836 UniProt SUBCELLULAR LOCATION "Mitochondrion matrix
{ECO:0000305|PubMed:8687463}."] Confirmed by high-confidence mitochondrial proteomics
[PMID:34800366 mitochondrial proteome, HTP]. Note a legacy LIFEdb IDA "cytoplasm" annotation
(GO:0005737) likely reflects an overexpressed GFP-fusion artifact, not the native location.

Tissue expression

Expressed in liver, kidney, pancreas, heart and skeletal muscle. PMID:8687463 Notably expressed in islets of Langerhans PMID:21990309.

Moonlighting / regulatory role: GDH inhibition and insulin secretion (HHF4 / HHF7)

Loss-of-function HADH mutations cause hyperinsulinaemic hypoglycaemia. This was the FIRST
fatty-acid-oxidation defect associated with hyperinsulinism, revealing a link between FAO and
insulin secretion.

  • First patient / P258L: PMID:11489939 The P258L variant abolishes catalytic activity PMID:11489939; <5% residual activity in
    fibroblast mitochondria PMID:11489939.
  • All early patients had hyperinsulinism, suggesting a regulatory role PMID:16725361.
  • MECHANISM (protein-protein, partly enzyme-independent): HADH binds and inhibits glutamate
    dehydrogenase 1 (GLUD1); loss of this inhibition de-represses GDH-driven amino-acid-stimulated
    insulin secretion. UniProt records this from mouse ortholog (Q61425): [Q16836 UniProt
    FUNCTION "Plays a role in the control of insulin secretion by inhibiting the activation of
    glutamate dehydrogenase 1 (GLUD1), an enzyme that has an important role in regulating amino
    acid-induced insulin secretion (By similarity)."] and [Q16836 UniProt SUBUNIT "Interacts with
    GLUD1; this interaction inhibits the activation of glutamate dehydrogenase 1 (GLUD1) (By
    similarity)."] This GDH-inhibition mechanism is the basis for it being "partly independent of
    beta-oxidation activity" — the protein-protein interaction is a separate molecular function
    (enzyme inhibitor activity) from the dehydrogenase catalysis.
  • Mouse Hadh-/- KO: elevated insulin, low glucose PMID:21990309; islets hypersecrete insulin PMID:21990309

Disease (UniProt): HADH deficiency [MIM:231530] (hypoglycemia, hepatoencephalopathy, myopathy/
cardiomyopathy, sudden death) and Hyperinsulinemic hypoglycemia familial 4 (HHF4) [MIM:609975].
(OMIM also uses HHF7 in some sources; UniProt entry uses HHF4.)

Thermogenesis / body weight (mouse; ISS in human)

Mouse KO data implicate Hadh in adaptive thermogenesis and body-weight regulation.
PMID:21990309 and
PMID:21990309 The GO term positive regulation of cold-induced thermogenesis
(GO:0120162) is ISS from mouse — a downstream physiological consequence of impaired FAO, not a
distinct molecular function; treat as non-core.

Spermatogenesis (By similarity, mouse)

UniProt: [Q16836 UniProt FUNCTION "Plays a role in the maintenance of normal spermatogenesis
through the reduction of fatty acid accumulation in the testes (By similarity)."] Keyword-derived
GO:0007283 (IEA from UniProtKB-KW). Downstream/By-similarity; non-core.

Annotation-review reasoning summary

  • Core MF: GO:0003857 (3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity — strongly supported
    by EXP/IDA (PMID:10231530, 11489939, 16725361), IBA, TAS. ACCEPT (core).
  • NAD+ binding GO:0070403 (IDA PMID:10840044) — ACCEPT; molecular detail of the catalytic MF.
  • identical protein binding GO:0042802 (IDA PMID:10231530) — homodimer; ACCEPT but non-core
    (descriptive of quaternary structure; the homodimer crystal structure supports it).
  • GO:0016509 long-chain (3S)-3-hydroxyacyl-CoA dehydrogenase activity (IEA RHEA) — HADH prefers
    short/medium chain; long-chain is HADHA. UniProt does list a long-chain Rhea reaction "By
    similarity" (ECO:0000250|UniProtKB:P00348, pig). MODIFY/over-annotation: the defining,
    preferred function is short/medium-chain; long-chain is at best minor. Mark as over-annotated /
    keep non-core rather than core. Use MARK_AS_OVER_ANNOTATED (does not contradict but misrepresents
    preference).
  • GO:0016491 oxidoreductase activity, GO:0016616 (CH-OH donor, NAD acceptor) — correct but
    generic parents of GO:0003857; KEEP_AS_NON_CORE.
  • GO:0016740 transferase activity (UniProtKB-KW, in DR lines) — NOT in GOA tsv, so not a row to
    review; the "Transferase" keyword is spurious for HADH (it is an oxidoreductase). Not in scope.
  • GO:0006631 fatty acid metabolic process (IEA InterPro), GO:0006635 fatty acid beta-oxidation
    (IBA, IDA, IEA) — beta-oxidation is the specific correct BP. ACCEPT GO:0006635 (core BP);
    GO:0006631 is the generic parent -> KEEP_AS_NON_CORE.
  • mitochondrion GO:0005739 (IBA is_active_in, IDA HPA, IEA, HTP, TAS) and mitochondrial matrix
    GO:0005759 (IEA SubCell, TAS Reactome x7) — matrix is correct specific location. ACCEPT matrix
    (core); mitochondrion = generic parent, KEEP_AS_NON_CORE.
  • cytoplasm GO:0005737 (IDA LIFEdb GO_REF:0000054) — overexpressed fusion-protein localization;
    HADH is matrix. MARK_AS_OVER_ANNOTATED (not native).
  • Insulin-secretion terms: regulation of insulin secretion GO:0050796 (ISS UniProtKB GO_REF:0000024
    from mouse Q61425; also IEA Ensembl) — well-supported moonlighting role; KEEP_AS_NON_CORE
    (genuine but secondary). negative regulation of insulin secretion GO:0046676 (IEA Ensembl) is
    more precise and matches the GDH-inhibition mechanism -> KEEP_AS_NON_CORE.
  • response to insulin GO:0032868, response to hormone GO:0009725, response to activity GO:0014823,
    response to xenobiotic GO:0009410 (all IEA Ensembl from rat ortholog) — generic transcriptional/
    physiological responses, weakly informative; KEEP_AS_NON_CORE (not contradicted, low value).
  • positive regulation of cold-induced thermogenesis GO:0120162 (ISS x2) — mouse KO phenotype;
    KEEP_AS_NON_CORE.
  • Reactome mitochondrial protein degradation rows (R-HSA-9838035/9838081/9838093/9838289) are
    CLPXP/LONP1 "binds/degrades matrix proteins" reactions — they annotate matrix LOCATION via
    HADH being a substrate, NOT a degradation function. The located_in GO:0005759 they assert is
    correct. ACCEPT as location evidence (non-core).

core_functions plan

  1. (3S)-3-hydroxyacyl-CoA dehydrogenase activity (GO:0003857) / fatty acid beta-oxidation
    (GO:0006635) / mitochondrial matrix (GO:0005759). PRIMARY.
  2. Enzyme inhibitor activity (GO:0004857) toward GLUD1 / negative regulation of insulin
    secretion (GO:0046676). SECONDARY moonlighting (By similarity / ISS — flag full_text basis).

📄 View Raw YAML

id: Q16836
gene_symbol: HADH
product_type: PROTEIN
status: COMPLETE
taxon:
  id: NCBITaxon:9606
  label: Homo sapiens
description: >-
  HADH (Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial; also known as SCHAD, HAD1,
  M/SCHAD) is a soluble mitochondrial matrix enzyme that catalyzes the third step of the
  fatty-acid beta-oxidation spiral: the NAD+-dependent oxidation of L-(3S)-3-hydroxyacyl-CoA
  to 3-ketoacyl-CoA (EC 1.1.1.35). It acts as a homodimer and preferentially oxidizes short-
  and medium-chain 3-hydroxyacyl-CoA substrates (roughly C4-C10), functionally distinct from
  the long-chain, membrane-associated mitochondrial trifunctional protein alpha subunit (HADHA).
  Catalysis uses His158 as a general base assisted by Glu170. Beyond its catalytic role, HADH
  has a well-documented regulatory (moonlighting) function in pancreatic beta-cells: it binds
  and inhibits the activation of glutamate dehydrogenase 1 (GLUD1), thereby restraining
  amino-acid-stimulated insulin secretion. Loss of HADH function causes hyperinsulinaemic
  hypoglycaemia and a fatty-acid-oxidation disorder, establishing the first known link between
  beta-oxidation and dysregulated insulin secretion. HADH is expressed in liver, kidney,
  pancreatic islets, heart, skeletal muscle, and adipose tissue, and in rodents contributes to
  body-weight regulation and adaptive thermogenesis.
alternative_products:
- name: '1'
  id: Q16836-1
- name: '2'
  id: Q16836-2
  sequence_note: VSP_016551, VSP_016552
- name: '3'
  id: Q16836-3
  sequence_note: VSP_016552
existing_annotations:
- term:
    id: GO:0003857
    label: (3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  qualifier: enables
  review:
    summary: >-
      Phylogenetically inferred core molecular function. This is the defining catalytic activity
      of HADH/SCHAD, directly demonstrated for the human enzyme by purified-protein biochemistry
      and crystallography and by patient-mutant expression studies. The IBA call is at the correct
      level of specificity and is strongly corroborated by experimental annotations on the same
      term.
    action: ACCEPT
    reason: >-
      Bona fide enzymatic function supported across the 3-hydroxyacyl-CoA dehydrogenase family and
      by direct human experimental data (PMID:10231530, PMID:11489939, PMID:16725361).
    supported_by:
    - reference_id: PMID:10231530
      supporting_text: "catalyzes the oxidation of the hydroxyl group of L-3-hydroxyacyl-CoA to a keto group, concomitant with the reduction of NAD+ to NADH"
- term:
    id: GO:0005739
    label: mitochondrion
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  qualifier: is_active_in
  review:
    summary: >-
      HADH is a mitochondrial matrix enzyme, so a mitochondrial location is correct. However,
      'mitochondrion' is the generic parent of the more precise and experimentally supported
      'mitochondrial matrix' (GO:0005759). Correct but non-core; the matrix term should carry the
      core localization.
    action: KEEP_AS_NON_CORE
    reason: >-
      Correct compartment but less specific than the supported mitochondrial matrix annotation.
- term:
    id: GO:0006635
    label: fatty acid beta-oxidation
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  qualifier: involved_in
  review:
    summary: >-
      Core biological process. HADH catalyzes the third step of the mitochondrial beta-oxidation
      cycle; this is its principal pathway role, supported by enzymology, the UniProt-curated
      pathway assignment, and patient deficiency phenotypes.
    action: ACCEPT
    reason: >-
      Directly supported by experimental data and UniProt pathway curation (lipid metabolism;
      fatty acid beta-oxidation).
    supported_by:
    - reference_id: PMID:11489939
      supporting_text: "This is the first defect in fatty acid beta-oxidation that has been associated with hyperinsulinism"
- term:
    id: GO:0003857
    label: (3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  qualifier: enables
  review:
    summary: >-
      Electronic (multi-method) inference of the core catalytic activity. Redundant with the
      experimental and IBA annotations on the same term and correct.
    action: ACCEPT
    reason: >-
      Same correct molecular function as the experimentally supported annotation.
- term:
    id: GO:0005759
    label: mitochondrial matrix
  evidence_type: IEA
  original_reference_id: GO_REF:0000044
  qualifier: located_in
  review:
    summary: >-
      Correct and specific subcellular localization derived from the UniProt subcellular-location
      vocabulary. HADH is a soluble matrix homodimer; this is the appropriate core location term
      and is independently supported by TAS (Reactome) and high-confidence mitochondrial proteomics.
    action: ACCEPT
    reason: >-
      Matches the curated UniProt 'Mitochondrion matrix' location and is the most precise
      localization for HADH.
- term:
    id: GO:0006631
    label: fatty acid metabolic process
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  qualifier: involved_in
  review:
    summary: >-
      Correct but generic. 'Fatty acid metabolic process' is a high-level parent of the specific
      and experimentally supported 'fatty acid beta-oxidation' (GO:0006635). Keep as non-core in
      favor of the more informative beta-oxidation term.
    action: KEEP_AS_NON_CORE
    reason: >-
      Subsumed by the more specific beta-oxidation annotation.
- term:
    id: GO:0016491
    label: oxidoreductase activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  qualifier: enables
  review:
    summary: >-
      Correct but maximally generic molecular-function class. HADH is an NAD+-dependent
      oxidoreductase, but this term is a distant parent of the specific GO:0003857 activity.
    action: KEEP_AS_NON_CORE
    reason: >-
      Generic parent of the specific dehydrogenase activity; uninformative as a standalone core
      function.
- term:
    id: GO:0016509
    label: long-chain (3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000116
  qualifier: enables
  review:
    summary: >-
      This Rhea-mapped annotation asserts long-chain (C16) 3-hydroxyacyl-CoA dehydrogenase
      activity. HADH is the SHORT/medium-chain enzyme (preferring C4-C10); the long-chain matrix
      activity is the dedicated function of HADHA (MTP alpha subunit). UniProt lists a long-chain
      Rhea reaction for HADH only 'By similarity' to pig liver SCHAD (P00348), not as a preferred
      human activity. Annotating HADH with the long-chain-specific term misrepresents substrate
      preference and overlaps the distinct HADHA function.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      HADH preferentially oxidizes short/medium-chain (C4-C10) 3-hydroxyacyl-CoAs; long-chain
      activity is minor/by-similarity and is the defining role of the paralog HADHA. The
      substrate-general GO:0003857 already captures the correct activity.
- term:
    id: GO:0016616
    label: oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP
      as acceptor
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  qualifier: enables
  review:
    summary: >-
      Correct but generic intermediate parent of GO:0003857. Accurately describes the chemistry
      (oxidation of a CH-OH group with NAD+ as acceptor) but is less informative than the specific
      activity term.
    action: KEEP_AS_NON_CORE
    reason: >-
      Generic parent of the specific 3-hydroxyacyl-CoA dehydrogenase activity.
- term:
    id: GO:0070403
    label: NAD+ binding
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  qualifier: enables
  review:
    summary: >-
      NAD+ is the cofactor for the dehydrogenase reaction and binding is documented
      crystallographically. Correct molecular detail of the catalytic mechanism; complementary to
      (and subordinate to) the core dehydrogenase activity rather than a standalone core function.
    action: KEEP_AS_NON_CORE
    reason: >-
      Cofactor-binding activity supporting the core catalytic function; also captured by the IDA
      annotation from PMID:10840044.
- term:
    id: GO:0005739
    label: mitochondrion
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  qualifier: located_in
  review:
    summary: >-
      Correct mitochondrial localization by orthology transfer, but generic relative to the
      specific 'mitochondrial matrix' term.
    action: KEEP_AS_NON_CORE
    reason: >-
      Less specific than the supported mitochondrial matrix annotation.
- term:
    id: GO:0006635
    label: fatty acid beta-oxidation
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  qualifier: involved_in
  review:
    summary: >-
      Electronic inference of the core beta-oxidation process, redundant with and consistent with
      the experimental (IDA) and IBA annotations on this term.
    action: ACCEPT
    reason: >-
      Correct core biological process supported by experimental evidence.
- term:
    id: GO:0009410
    label: response to xenobiotic stimulus
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  qualifier: involved_in
  review:
    summary: >-
      Electronically transferred from a rodent ortholog (rat Q9WVK7). A generic physiological
      'response' term with no mechanistic link to HADH's molecular function; weakly informative
      and not part of the gene's core biology.
    action: KEEP_AS_NON_CORE
    reason: >-
      Orthology-transferred generic response term; not contradicted but low information and not a
      core function.
- term:
    id: GO:0009725
    label: response to hormone
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  qualifier: involved_in
  review:
    summary: >-
      Generic 'response to hormone' transferred electronically from a rodent ortholog. Broad and
      mechanistically uninformative for HADH.
    action: KEEP_AS_NON_CORE
    reason: >-
      Orthology-transferred generic term; non-core.
- term:
    id: GO:0014823
    label: response to activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  qualifier: involved_in
  review:
    summary: >-
      Generic physiological response term transferred from a rodent ortholog; not informative
      about HADH molecular function.
    action: KEEP_AS_NON_CORE
    reason: >-
      Orthology-transferred generic term; non-core.
- term:
    id: GO:0032868
    label: response to insulin
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  qualifier: involved_in
  review:
    summary: >-
      Generic 'response to insulin' transferred from a rodent ortholog. While HADH biology is
      linked to insulin (through its regulatory effect ON secretion), 'response to insulin' is a
      distinct, broad term and is mechanistically uninformative here.
    action: KEEP_AS_NON_CORE
    reason: >-
      Orthology-transferred generic response term; the relevant insulin biology is captured by the
      regulation-of-insulin-secretion annotations.
- term:
    id: GO:0046676
    label: negative regulation of insulin secretion
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  qualifier: involved_in
  review:
    summary: >-
      Captures HADH's regulatory (moonlighting) role in pancreatic beta-cells: by binding and
      inhibiting GLUD1, HADH restrains amino-acid-stimulated insulin secretion, so its loss leads
      to inappropriate insulin oversecretion (hyperinsulinism). This is the more mechanistically
      precise insulin-secretion term and is well supported by human disease and mouse knockout
      data. Genuine secondary function.
    action: KEEP_AS_NON_CORE
    reason: >-
      Well-supported regulatory function (GDH inhibition / restraint of insulin secretion), but
      secondary to the core beta-oxidation enzymatic role.
    supported_by:
    - reference_id: PMID:21990309
      supporting_text: "insulin secretion in response to glucose and glucose plus palmitate was elevated in isolated islets of knockout mice"
- term:
    id: GO:0050796
    label: regulation of insulin secretion
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  qualifier: involved_in
  review:
    summary: >-
      Parent term of 'negative regulation of insulin secretion'. Correct and supported, but less
      precise than the negative-regulation child that matches the GDH-inhibition mechanism.
    action: KEEP_AS_NON_CORE
    reason: >-
      Correct regulatory role but subsumed by the more specific negative-regulation term.
- term:
    id: GO:0120162
    label: positive regulation of cold-induced thermogenesis
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  qualifier: involved_in
  review:
    summary: >-
      Based on the mouse Hadh knockout phenotype (impaired cold tolerance / adaptive
      thermogenesis). This is a downstream physiological consequence of impaired fatty-acid
      oxidation rather than a distinct molecular function of HADH; appropriate to retain as a
      non-core, organism-level process.
    action: KEEP_AS_NON_CORE
    reason: >-
      Mouse-derived physiological phenotype downstream of FAO; non-core.
    supported_by:
    - reference_id: PMID:21990309
      supporting_text: "SCHAD plays an important role in adaptive thermogenesis"
- term:
    id: GO:0005739
    label: mitochondrion
  evidence_type: IDA
  original_reference_id: GO_REF:0000052
  qualifier: located_in
  review:
    summary: >-
      Direct (immunofluorescence/HPA) evidence for mitochondrial localization. Correct; generic
      relative to the matrix sub-compartment but a valid experimental localization.
    action: KEEP_AS_NON_CORE
    reason: >-
      Experimentally supported mitochondrial localization, less specific than mitochondrial matrix.
- term:
    id: GO:0003857
    label: (3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity
  evidence_type: EXP
  original_reference_id: PMID:10231530
  qualifier: enables
  review:
    summary: >-
      Direct experimental demonstration of the core catalytic activity via purified recombinant
      human heart SCHAD, kinetics, and crystal structures of the enzyme with NAD+ and substrate.
      This is the strongest evidence for HADH's defining molecular function.
    action: ACCEPT
    reason: >-
      Gold-standard experimental evidence for the core dehydrogenase activity.
    supported_by:
    - reference_id: PMID:10231530
      supporting_text: "catalyzes the oxidation of the hydroxyl group of L-3-hydroxyacyl-CoA to a keto group, concomitant with the reduction of NAD+ to NADH"
- term:
    id: GO:0003857
    label: (3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity
  evidence_type: EXP
  original_reference_id: PMID:16725361
  qualifier: enables
  review:
    summary: >-
      Experimental support from kinetic analysis of patient-derived missense mutants (D45G with
      altered NADH Km; Y214H with no detectable activity), directly assaying the human SCHAD
      3-hydroxyacyl-CoA dehydrogenase activity.
    action: ACCEPT
    reason: >-
      Independent experimental confirmation of the core dehydrogenase activity through mutant
      enzymology.
- term:
    id: GO:0005739
    label: mitochondrion
  evidence_type: HTP
  original_reference_id: PMID:34800366
  qualifier: located_in
  review:
    summary: >-
      High-throughput high-confidence mitochondrial proteomics confirming HADH as a mitochondrial
      protein. Correct; generic relative to the matrix term but a valid orthogonal localization
      evidence source.
    action: KEEP_AS_NON_CORE
    reason: >-
      Supports mitochondrial localization; less specific than mitochondrial matrix.
- term:
    id: GO:0050796
    label: regulation of insulin secretion
  evidence_type: ISS
  original_reference_id: GO_REF:0000024
  qualifier: involved_in
  review:
    summary: >-
      Sequence-similarity transfer (from mouse Q61425) of HADH's regulatory role in insulin
      secretion. Reflects the GDH-inhibition moonlighting mechanism. Correct and supported, but
      less precise than the negative-regulation child term and secondary to the core enzymatic
      function.
    action: KEEP_AS_NON_CORE
    reason: >-
      Genuine but secondary regulatory function; the negative-regulation term is more precise.
    supported_by:
    - reference_id: PMID:21990309
      supporting_text: "Blood glucose concentrations in the fasted and postprandial state were significantly lower in hadh(-/-) mice, whereas insulin levels were elevated"
- term:
    id: GO:0070403
    label: NAD+ binding
  evidence_type: IDA
  original_reference_id: PMID:10840044
  qualifier: enables
  review:
    summary: >-
      Direct crystallographic/spectroscopic evidence for NAD+/NADH binding within distinct enzyme
      conformations. A molecular detail underpinning the catalytic mechanism; complementary to the
      core dehydrogenase activity.
    action: KEEP_AS_NON_CORE
    reason: >-
      Cofactor-binding activity supporting, but subordinate to, the core catalytic function.
    supported_by:
    - reference_id: PMID:10840044
      supporting_text: "significant shifting of the NAD(+)-binding domain relative to the C-terminal domain occurs in the ternary and substrate-bound complexes"
- term:
    id: GO:0042802
    label: identical protein binding
  evidence_type: IDA
  original_reference_id: PMID:10231530
  qualifier: enables
  review:
    summary: >-
      Reflects the fact that HADH is an obligate homodimer, established by crystallography and
      biochemistry. This is a quaternary-structure descriptor ('identical protein binding') rather
      than the bare uninformative 'protein binding', and it is experimentally grounded. It is not,
      however, a core catalytic/regulatory function in its own right.
    action: KEEP_AS_NON_CORE
    reason: >-
      Experimentally supported self-association (homodimerization); structural property rather than
      a core function.
    supported_by:
    - reference_id: PMID:10231530
      supporting_text: "The homodimeric enzyme has been overexpressed in Escherichia coli, purified to homogeneity"
- term:
    id: GO:0003857
    label: (3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity
  evidence_type: IDA
  original_reference_id: PMID:11489939
  qualifier: enables
  review:
    summary: >-
      Direct assay of the core activity in patient material and recombinant enzyme: SCHAD activity
      was markedly reduced in patient fibroblast mitochondria and the P258L variant had no
      catalytic activity, confirming HADH as the enzyme catalyzing this reaction.
    action: ACCEPT
    reason: >-
      Experimental loss-of-function evidence directly tying HADH to the 3-hydroxyacyl-CoA
      dehydrogenase activity.
    supported_by:
    - reference_id: PMID:11489939
      supporting_text: "Expression studies showed that the P258L enzyme had no catalytic activity"
- term:
    id: GO:0006635
    label: fatty acid beta-oxidation
  evidence_type: IDA
  original_reference_id: PMID:11489939
  qualifier: involved_in
  review:
    summary: >-
      Direct evidence linking HADH to beta-oxidation: deficiency produces a fatty-acid-oxidation
      disorder with characteristic 3-hydroxy-acylcarnitine accumulation, the first FAO defect
      associated with hyperinsulinism.
    action: ACCEPT
    reason: >-
      Experimentally supported core biological process (beta-oxidation).
    supported_by:
    - reference_id: PMID:11489939
      supporting_text: "This is the first defect in fatty acid beta-oxidation that has been associated with hyperinsulinism"
- term:
    id: GO:0120162
    label: positive regulation of cold-induced thermogenesis
  evidence_type: ISS
  original_reference_id: PMID:21990309
  qualifier: involved_in
  review:
    summary: >-
      Sequence-similarity annotation citing the mouse Hadh knockout thermogenesis phenotype.
      Downstream physiological consequence of impaired fatty-acid oxidation rather than a distinct
      molecular function; retain as non-core.
    action: KEEP_AS_NON_CORE
    reason: >-
      Mouse-derived organismal phenotype downstream of FAO; non-core.
    supported_by:
    - reference_id: PMID:21990309
      supporting_text: "SCHAD plays an important role in adaptive thermogenesis"
- term:
    id: GO:0005759
    label: mitochondrial matrix
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-77254
  qualifier: located_in
  review:
    summary: >-
      Reactome traceable assertion placing HADH in the mitochondrial matrix as part of a
      beta-oxidation reaction (3-hydroxydodecanoyl-CoA oxidation). Correct, specific localization
      consistent with UniProt.
    action: ACCEPT
    reason: >-
      Correct, specific mitochondrial matrix localization from curated pathway data.
- term:
    id: GO:0005759
    label: mitochondrial matrix
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-77312
  qualifier: located_in
  review:
    summary: >-
      Reactome matrix localization within the short-chain (3-hydroxybutanoyl-CoA) beta-oxidation
      reaction. Correct and consistent with the curated location.
    action: ACCEPT
    reason: >-
      Correct mitochondrial matrix localization from curated pathway data.
- term:
    id: GO:0005759
    label: mitochondrial matrix
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-77323
  qualifier: located_in
  review:
    summary: >-
      Reactome matrix localization within the hexanoyl-CoA beta-oxidation reaction. Correct,
      consistent with curated location.
    action: ACCEPT
    reason: >-
      Correct mitochondrial matrix localization from curated pathway data.
- term:
    id: GO:0005759
    label: mitochondrial matrix
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-77331
  qualifier: located_in
  review:
    summary: >-
      Reactome matrix localization within the octanoyl-CoA beta-oxidation reaction. Correct,
      consistent with curated location.
    action: ACCEPT
    reason: >-
      Correct mitochondrial matrix localization from curated pathway data.
- term:
    id: GO:0005759
    label: mitochondrial matrix
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-77342
  qualifier: located_in
  review:
    summary: >-
      Reactome matrix localization within the decanoyl-CoA beta-oxidation reaction. Correct,
      consistent with curated location.
    action: ACCEPT
    reason: >-
      Correct mitochondrial matrix localization from curated pathway data.
- term:
    id: GO:0005759
    label: mitochondrial matrix
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9838035
  qualifier: located_in
  review:
    summary: >-
      This Reactome reaction is 'CLPXP binds mitochondrial matrix proteins'; HADH is annotated
      here as a matrix substrate of the quality-control protease, which correctly localizes it to
      the matrix. The location assertion is valid; it does not imply any protease/degradation
      function for HADH itself.
    action: ACCEPT
    reason: >-
      Valid matrix localization arising from HADH being a CLPXP substrate (localization-only, not a
      HADH function).
- term:
    id: GO:0005759
    label: mitochondrial matrix
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9838081
  qualifier: located_in
  review:
    summary: >-
      Reactome 'LONP1 degrades mitochondrial matrix proteins'; HADH appears as a matrix substrate,
      correctly localizing it to the matrix. Location-only evidence, not a degradation function of
      HADH.
    action: ACCEPT
    reason: >-
      Valid matrix localization from HADH being a LONP1 substrate (localization-only).
- term:
    id: GO:0005759
    label: mitochondrial matrix
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9838093
  qualifier: located_in
  review:
    summary: >-
      Reactome 'LONP1 binds mitochondrial matrix proteins'; HADH appears as a matrix substrate.
      Correct localization; location-only, not a HADH function.
    action: ACCEPT
    reason: >-
      Valid matrix localization from HADH being a LONP1 substrate (localization-only).
- term:
    id: GO:0005759
    label: mitochondrial matrix
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9838289
  qualifier: located_in
  review:
    summary: >-
      Reactome 'CLPXP degrades mitochondrial matrix proteins'; HADH appears as a matrix substrate.
      Correct localization; location-only, not a HADH function.
    action: ACCEPT
    reason: >-
      Valid matrix localization from HADH being a CLPXP substrate (localization-only).
- term:
    id: GO:0005737
    label: cytoplasm
  evidence_type: IDA
  original_reference_id: GO_REF:0000054
  qualifier: located_in
  review:
    summary: >-
      A LIFEdb annotation based on localization of an expressed fluorescent fusion protein in
      living cells. HADH is a mitochondrial matrix enzyme with a cleavable N-terminal mitochondrial
      targeting peptide; a cytoplasmic call most likely reflects mislocalization of the
      overexpressed fusion construct (e.g., incomplete import or a tag obscuring the transit
      peptide) rather than the native location. Contradicted by curated UniProt localization,
      Reactome, HPA, and high-confidence mitochondrial proteomics.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      Likely overexpression/fusion-protein artifact; HADH is matrix-localized, not cytoplasmic.
- term:
    id: GO:0003857
    label: (3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity
  evidence_type: TAS
  original_reference_id: PMID:8687463
  qualifier: enables
  review:
    summary: >-
      Traceable assertion from the original human SCHAD cDNA cloning/characterization paper, which
      identified the protein as short-chain L-3-hydroxyacyl-CoA dehydrogenase. Correct core
      molecular function.
    action: ACCEPT
    reason: >-
      Consistent with the experimentally established core dehydrogenase activity.
    supported_by:
    - reference_id: PMID:8687463
      supporting_text: "The cDNA encompassing the complete coding sequence of human liver short-chain L-3-hydroxyacyl-CoA dehydrogenase (SCHAD) was isolated and characterized"
- term:
    id: GO:0005739
    label: mitochondrion
  evidence_type: TAS
  original_reference_id: PMID:8687463
  qualifier: located_in
  review:
    summary: >-
      Traceable assertion of mitochondrial localization from the cloning paper, which identified a
      12-residue mitochondrial import signal peptide. Correct; generic relative to the matrix term.
    action: KEEP_AS_NON_CORE
    reason: >-
      Correct mitochondrial localization, less specific than mitochondrial matrix.
    supported_by:
    - reference_id: PMID:8687463
      supporting_text: "containing a mitochondrial import signal peptide of 12 amino acids"
core_functions:
- description: >-
    Core enzymatic function: HADH catalyzes the third step of the mitochondrial fatty-acid
    beta-oxidation spiral, the NAD+-dependent oxidation of L-(3S)-3-hydroxyacyl-CoA to
    3-ketoacyl-CoA, acting as a soluble homodimer in the mitochondrial matrix and preferring
    short/medium-chain (C4-C10) substrates.
  molecular_function:
    id: GO:0003857
    label: (3S)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity
  directly_involved_in:
  - id: GO:0006635
    label: fatty acid beta-oxidation
  locations:
  - id: GO:0005759
    label: mitochondrial matrix
  supported_by:
  - reference_id: PMID:10231530
    supporting_text: "catalyzes the oxidation of the hydroxyl group of L-3-hydroxyacyl-CoA to a keto group, concomitant with the reduction of NAD+ to NADH"
  - reference_id: PMID:11489939
    supporting_text: "Expression studies showed that the P258L enzyme had no catalytic activity"
- description: >-
    Secondary (moonlighting) regulatory function: in pancreatic beta-cells HADH binds and
    inhibits the activation of glutamate dehydrogenase 1 (GLUD1), thereby restraining
    amino-acid-stimulated insulin secretion. Loss of HADH de-represses GLUD1 and causes
    inappropriate insulin oversecretion (hyperinsulinaemic hypoglycaemia), a phenotype
    reproduced in Hadh knockout mice and partly independent of beta-oxidation flux. The
    underlying molecular activity is enzyme (GLUD1) inhibitor activity; the physiological
    output is negative regulation of insulin secretion.
  molecular_function:
    id: GO:0004857
    label: enzyme inhibitor activity
  directly_involved_in:
  - id: GO:0046676
    label: negative regulation of insulin secretion
  locations:
  - id: GO:0005759
    label: mitochondrial matrix
  supported_by:
  - reference_id: PMID:20670938
    supporting_text: "showed protein-protein interactions between SCHAD and GDH"
  - reference_id: PMID:20670938
    supporting_text: "reflecting the loss of an inhibitory protein-protein interaction of SCHAD upon GDH"
  - reference_id: PMID:21990309
    supporting_text: "insulin secretion in response to glucose and glucose plus palmitate was elevated in isolated islets of knockout mice"
proposed_new_terms: []
suggested_questions:
- question: >-
    To what extent is HADH's regulation of insulin secretion mediated by direct GLUD1 inhibition
    versus by perturbation of short-chain acyl-CoA/3-hydroxyacyl-CoA pools from impaired
    beta-oxidation, and are these mechanisms separable in human beta-cells?
- question: >-
    Is the HADH-GLUD1 inhibitory interaction conserved and direct in human tissue (as opposed to
    the By-similarity/mouse-based evidence currently underpinning it), and what is its
    stoichiometry and regulation?
suggested_experiments:
- description: >-
    Reconstitute purified human HADH with human GLUD1 in vitro and measure GLUD1 activity +/-
    HADH (and +/- HADH catalytic-dead mutants) to determine whether enzyme-inhibitor activity is
    independent of HADH's own catalysis.
- description: >-
    Generate beta-cell models expressing a catalytically dead but folding-competent HADH variant
    versus full knockout to dissociate the dehydrogenase activity from the GLUD1-inhibition /
    insulin-secretion-restraint function.
- description: >-
    Perform substrate-profiling (chain-length kinetics) on purified human HADH across C4-C16
    3-hydroxyacyl-CoAs to quantitatively confirm short/medium-chain preference and the negligible
    long-chain activity relative to HADHA.
references:
- id: GO_REF:0000002
  title: Gene Ontology annotation through association of InterPro records with GO terms
  findings: []
- id: GO_REF:0000024
  title: Manual transfer of experimentally-verified manual GO annotation data to orthologs
    by curator judgment of sequence similarity
  findings: []
- id: GO_REF:0000033
  title: Annotation inferences using phylogenetic trees
  findings: []
- id: GO_REF:0000044
  title: Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location
    vocabulary mapping, accompanied by conservative changes to GO terms applied by
    UniProt
  findings: []
- id: GO_REF:0000052
  title: Gene Ontology annotation based on curation of immunofluorescence data
  findings: []
- id: GO_REF:0000054
  title: Gene Ontology annotation based on curation of intracellular localizations
    of expressed fusion proteins in living cells
  findings: []
- id: GO_REF:0000107
  title: Automatic transfer of experimentally verified manual GO annotation data to
    orthologs using Ensembl Compara
  findings: []
- id: GO_REF:0000116
  title: Automatic Gene Ontology annotation based on Rhea mapping
  findings: []
- id: GO_REF:0000120
  title: Combined Automated Annotation using Multiple IEA Methods
  findings: []
- id: PMID:10231530
  title: Biochemical characterization and crystal structure determination of human
    heart short chain L-3-hydroxyacyl-CoA dehydrogenase provide insights into catalytic
    mechanism.
  findings:
  - statement: >-
      Human heart SCHAD catalyzes NAD+-dependent oxidation of L-3-hydroxyacyl-CoA to a 3-keto
      product as part of beta-oxidation; the enzyme is a homodimer and was characterized
      biochemically and crystallographically with NAD+/substrate.
    supporting_text: "catalyzes the oxidation of the hydroxyl group of L-3-hydroxyacyl-CoA to a keto group, concomitant with the reduction of NAD+ to NADH"
  - statement: >-
      Catalytic mechanism: His158 acts as a general base abstracting the 3-OH proton, assisted by
      Glu170.
    supporting_text: "His 158 serves as a general base, abstracting a proton from the 3-OH group of the substrate"
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: >-
      PubMed-verified primary biochemistry/structure paper establishing the human SCHAD core
      catalytic activity, homodimer, and mechanism. Abstract-only in cache.
- id: PMID:10840044
  title: Sequestration of the active site by interdomain shifting. Crystallographic
    and spectroscopic evidence for distinct conformations of L-3-hydroxyacyl-CoA dehydrogenase.
  findings:
  - statement: >-
      Crystal structures of apo-, cofactor-, and substrate-bound forms reveal NAD+-binding domain
      shifting relative to the C-terminal domain; supports NAD+ binding and catalytic mechanism.
    supporting_text: "significant shifting of the NAD(+)-binding domain relative to the C-terminal domain occurs in the ternary and substrate-bound complexes"
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: >-
      PubMed-verified structural follow-up supporting NAD+ binding and the catalytic conformational
      cycle. Abstract-only in cache.
- id: PMID:11489939
  title: Hyperinsulinism in short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency
    reveals the importance of beta-oxidation in insulin secretion.
  findings:
  - statement: >-
      First report linking a fatty-acid-oxidation defect (SCHAD/HADH deficiency, P258L) to
      hyperinsulinism, establishing HADH's role in insulin-secretion regulation.
    supporting_text: "This is the first defect in fatty acid beta-oxidation that has been associated with hyperinsulinism"
  - statement: >-
      The disease-causing P258L variant abolishes catalytic activity, directly tying HADH to the
      3-hydroxyacyl-CoA dehydrogenase reaction.
    supporting_text: "Expression studies showed that the P258L enzyme had no catalytic activity"
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: >-
      PubMed-verified case report establishing the HADH-hyperinsulinism link and confirming loss of
      catalytic activity in a pathogenic variant. Abstract-only in cache.
- id: PMID:16725361
  title: Reye-like syndrome resulting from novel missense mutations in mitochondrial
    medium- and short-chain l-3-hydroxy-acyl-CoA dehydrogenase.
  findings:
  - statement: >-
      Kinetic analysis of patient-derived M/SCHAD mutants (D45G altered NADH Km; Y214H no activity)
      confirms the human enzyme's 3-hydroxyacyl-CoA dehydrogenase activity and broadens the
      phenotype; supports a role in insulin regulation.
    supporting_text: "This association suggests that there is a role for M/SCHAD in regulating the pancreatic secretion of insulin"
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: >-
      PubMed-verified case report with mutant enzymology supporting the core activity and the
      insulin-regulation role. Abstract-only in cache.
- id: PMID:20670938
  title: Mechanism of hyperinsulinism in short-chain 3-hydroxyacyl-CoA dehydrogenase
    deficiency involves activation of glutamate dehydrogenase.
  findings:
  - statement: >-
      Definitive mechanistic paper: pull-down experiments demonstrate a direct protein-protein
      interaction between SCHAD (HADH) and glutamate dehydrogenase (GDH), and show that SCHAD
      deficiency activates GDH by removing this inhibitory interaction, dysregulating
      amino-acid-stimulated insulin secretion. Establishes the GLUD1-inhibitor moonlighting
      function on firmer footing than the earlier speculative reports.
    supporting_text: "reflecting the loss of an inhibitory protein-protein interaction of SCHAD upon GDH"
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: >-
      PubMed-verified, full text available; provides the definitive protein-protein interaction and
      loss-of-inhibition evidence for the HADH/GLUD1 regulatory function.
- id: PMID:21990309
  title: Role of medium- and short-chain L-3-hydroxyacyl-CoA dehydrogenase in the
    regulation of body weight and thermogenesis.
  findings:
  - statement: >-
      Hadh-knockout mice show low glucose and elevated insulin, and isolated islets hypersecrete
      insulin in response to glucose and palmitate, supporting HADH's negative regulation of
      insulin secretion.
    supporting_text: "insulin secretion in response to glucose and glucose plus palmitate was elevated in isolated islets of knockout mice"
  - statement: >-
      Hadh knockout impairs adaptive thermogenesis and body-weight regulation under high-fat/cold
      conditions.
    supporting_text: "SCHAD plays an important role in adaptive thermogenesis"
  - statement: >-
      SCHAD/HADH is highly expressed in pancreatic islets of Langerhans, consistent with a direct
      role in beta-cell function.
    supporting_text: "in the islets of Langerhans within the pancreas"
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: >-
      PubMed-verified mouse knockout study (full text available) supporting insulin-secretion
      regulation, thermogenesis, and islet expression.
- id: PMID:34800366
  title: Quantitative high-confidence human mitochondrial proteome and its dynamics
    in cellular context.
  findings:
  - statement: >-
      HADH is identified in a high-confidence quantitative human mitochondrial proteome,
      corroborating its mitochondrial localization.
    supporting_text: "Quantitative high-confidence human mitochondrial proteome and its dynamics"
  reference_review:
    relevance: MEDIUM
    correctness: VERIFIED
    review_notes: >-
      High-throughput mitochondrial proteomics providing orthogonal support for mitochondrial
      localization.
- id: PMID:8687463
  title: 'Human short-chain L-3-hydroxyacyl-CoA dehydrogenase: cloning and characterization
    of the coding sequence.'
  findings:
  - statement: >-
      Original cloning of human SCHAD cDNA; encodes a 314-aa protein with a 12-residue
      mitochondrial import peptide; expressed in liver, kidney, pancreas, heart and skeletal
      muscle.
    supporting_text: "Northern blot analysis reveals SCHAD mRNA to be expressed in liver, kidney, pancreas, heart and skeletal muscle"
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: >-
      PubMed-verified original characterization establishing identity, mitochondrial targeting, and
      tissue expression. Abstract-only in cache.
- id: Reactome:R-HSA-77254
  title: (S)-3-Hydroxydodecanoyl-CoA+NAD => 3-Oxododecanoyl-CoA+NADH+H
  findings: []
- id: Reactome:R-HSA-77312
  title: (S)-Hydroxybutanoyl-CoA+NAD => Acetoacetyl-CoA+NADH+H
  findings: []
- id: Reactome:R-HSA-77323
  title: (S)-Hydroxyhexanoyl-CoA+NAD => 3-Oxohexanoyl-CoA+NADH+H
  findings: []
- id: Reactome:R-HSA-77331
  title: (S)-Hydroxyoctanoyl-CoA+NAD => 3-Oxooctanoyl-CoA+NADH+H
  findings: []
- id: Reactome:R-HSA-77342
  title: (S)-Hydroxydecanoyl-CoA+NAD => 3-Oxodecanoyl-CoA+NADH+H
  findings: []
- id: Reactome:R-HSA-9838035
  title: CLPXP binds mitochondrial matrix proteins
  findings: []
- id: Reactome:R-HSA-9838081
  title: LONP1 degrades mitochondrial matrix proteins
  findings: []
- id: Reactome:R-HSA-9838093
  title: LONP1 binds mitochondrial matrix proteins
  findings: []
- id: Reactome:R-HSA-9838289
  title: CLPXP degrades mitochondrial matrix proteins
  findings: []